Price$16.34-0.22 (-1.33%)
01:30 PM06:00 PM
News · 26 weeks62+200%
2026-04-192026-10-11
Mix3190d
- SEC Filings8(26%)
- Other9(29%)
- Insider7(23%)
- Offering4(13%)
- Earnings2(6%)
- Analyst1(3%)
Latest news
25 items- PRHercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.Fitch Additionally Affirms Secured Debt Rating at BBB Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. ("Fitch") has affirmed Hercules’ investment grade corporate and unsecured credit rating of BBB-, and affirmed the Company’s secured debt rating of BBB, with a stable outlook, as well as its underlying analysis. "We are very pleased that Fitch has affirmed both our BBB- investment grade corporate and unsec
- PRHercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference CallHercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2026 financial results conference call for Thursday, October 29, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Relations section
- INSIDERSEC Form 4 filed by Hercules Capital Inc.4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Hercules Capital Inc.4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Hercules Capital Inc.4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Hercules Capital Inc.4 - Hercules Capital, Inc. (0001280784) (Issuer)
- SECSEC Form 8-K filed by Hercules Capital Inc.8-K - Hercules Capital, Inc. (0001280784) (Filer)
- PRHercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029Notes due 2029 Initially Assigned Ratings of Baa2 by Moody’s Investors Service and BBB- by Fitch Ratings, Inc. Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), today announced that it has closed an upsized underwritten public offering of $400.0 million in aggregate principal amount of 6.700% notes due October 2029 (the "Notes"). The Notes are unsecured and bear interest at a rate of 6.700% per year, payable semiannually, will mature on October 8, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company’s option at par, plus a "make whole" premium, if applicable. The Company expects to use the net proceeds from t
- PRRocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules CapitalRocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that it has entered into a credit facility agreement with Hercules Capital, Inc. (NYSE:HTGC) for up to $150 million. The facility strengthens Rocket’s financial position and provides access to additional capital to support execution of its pivotal Phase 2 study of RP-A501 for Danon disease and continued advancement of its broader cardiovascular pipeline. "Building on the sale of our priority review voucher, this financing diversifies our sources of capital an
- SECSEC Form 497AD filed by Hercules Capital Inc.497AD - Hercules Capital, Inc. (0001280784) (Filer)
- SECSEC Form FWP filed by Hercules Capital Inc.FWP - Hercules Capital, Inc. (0001280784) (Subject)
- PRHercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes due 2029Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), today announced that it has priced an underwritten public offering of $400.0 million in aggregate principal amount of 6.70% notes due October 2029 (the "Notes"). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on October 8, 2026.The Notes are unsecured and bear interest at a rate of 6.70% per year, payable semiannually and will mature on October 8, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company’s option at par, plus a "make whole" premium, if applicable.The Company expects to use
- PRNorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer TherapiesMulti-year growth-capital facility to fuel NorthStar’s commercial production scale-up of no-carrier-added Actinium-225 (n.c.a. Ac-225) to meet growing demand for next-generation targeted alpha therapies. Capital will accelerate expansion of NorthStar’s vertically integrated radiopharmaceutical campus, including co-located isotope production and state-of-the-art Contract Development and Manufacturing Organization (CDMO). Follows FDA acceptance of NorthStar’s Drug Master File for n.c.a. Ac-225 and the first commercial-scale production of the isotope in January 2026; High-capacity production line to be active later this year. NorthStar Medical Technologies, LLC (NorthStar), the first
- INSIDERNew insider Fichera Alfred claimed no ownership of stock in the company (SEC Form 3)3 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERDirector Fichera Alfred was granted 3,483 shares (SEC Form 4)4 - Hercules Capital, Inc. (0001280784) (Issuer)
- SECHercules Capital Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits8-K - Hercules Capital, Inc. (0001280784) (Filer)
- PRHercules Capital Announces the Appointment of Alfred B. Fichera to Its Board of DirectorsHercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Alfred B. Fichera was appointed to serve as an independent member of its board of directors, effective September 17, 2026. Mr. Fichera is an experienced audit and accounting professional and board director with more than 40 years across the financial services and asset management industries. Mr. Fichera will serve on the Company’s Audit Committee. "As we continue to expand and
- INSIDERPresident Meyer Seth H covered exercise/tax liability with 5 shares, decreasing direct ownership by 0.00% to 435,600 units (SEC Form 4)4 - Hercules Capital, Inc. (0001280784) (Issuer)
- PRHercules Capital’s Investment Adviser Surpasses $2.3 Billion in Investable CapitalNew Equity Commitments Raised Across Two Institutional Private Credit Vehicles, Hercules Growth Lending IV and Hercules Evergreen Fund, Alongside a Rated Note Offering Hercules Evergreen Fund is the Adviser’s Inaugural Perpetual, Open-End Vehicle and Its Fifth Institutional Private Credit Vehicle Launched Since the Platform’s Creation in 2021 Together with Hercules Capital, the Firm Manages Approximately $6.1 Billion of Assets Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and
- ANALYSTHercules Capital upgraded by UBS with a new price targetUBS upgraded Hercules Capital from Neutral to Buy and set a new price target of $18.50
- PRHercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Kroll Bond Rating Agency, Inc. ("KBRA") has affirmed Hercules’ investment grade corporate and credit rating of BBB+. KBRA issued a statement announcing the affirmation of the rating and stable outlook, as well as its underlying analysis. The affirmed BBB+ rating reflects the Company’s diversified investment portfolio with a focus on senior secured first lien venture debt investme
- SECHercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits8-K - Hercules Capital, Inc. (0001280784) (Filer)
- SECSEC Form 10-Q filed by Hercules Capital Inc.10-Q - Hercules Capital, Inc. (0001280784) (Filer)
- PRHercules Capital Reports Second Quarter 2026 Financial ResultsRecord 1H 2026 Total New Debt and Equity Commitments of $2.74 Billion, an Increase of 35.6% Year-over-Year Record 1H 2026 Total Fundings of $1.35 Billion, an Increase of 8.5% Year-over-Year Record 1H 2026 Total Investment Income of $290.7 Million, an Increase of 13.1% Year-over-Year Record 1H 2026 Net Investment Income "NII" of $181.0 Million, an Increase of 8.9% Year-over-Year Record Q2 2026 Total Investment Income of $149.1 Million, an Increase of 8.5% Year-over-Year Record Q2 2026 NII of $92.9 Million, an Increase of 4.7% Year-over-Year Q2 2026 NII of $0.50 per Share provides 125% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net GAAP Lev
- PRHercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2026The Total Cash Distribution of $0.47 per Share for the Second Quarter 2026 is Comprised of a $0.40 per Share Base Distribution and $0.07 per Share Supplemental Distribution Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second quarter 2026 total cash distribution of $0.47 per share. The following shows the key dates of the second quarter 2026 distribution payment: Record Date
HTGC FAQ
8 questionsWhat does Hercules Capital Inc. do?
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and...Where does HTGC stock trade?
Hercules Capital Inc. (HTGC) is listed on NYSE.What sector and industry is HTGC in?
Hercules Capital Inc. operates in the Finance sector, Investment Managers industry.When did Hercules Capital Inc. go public?
Hercules Capital Inc. (HTGC) completed its IPO in 2012.Does HTGC pay a dividend?
HTGC's most recent ex-dividend date was 2026-08-11 with a cash dividend of $0.07 per share. No future ex-date is on file yet.What are analysts saying about HTGC?
Hercules Capital Inc. has had 8 recent analyst actions on file. The most recent action was from UBS: Buy with a $1850.00 price target on 2026-09-01. Recent price targets range from $1700.00 to $2150.00.What companies are similar to HTGC?
Notable peers in the same industry include BX (Blackstone Inc.), KKR (KKR & Co. Inc.), APO (Apollo Global Management Inc. (New)), AMP (Ameriprise Financial Inc.), ARES (Ares Management Corporation). Compare HTGC side-by-side with any of them on Quantisnow.How can I track HTGC on Quantisnow?
Quantisnow aggregates Hercules Capital Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HTGC to receive live email and push alerts on every new disclosure.